Stay updated on Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.

Latest updates to the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.0.2; removed Revision: v3.0.1 and the Back to Top link.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, including specific drug information for Fruquintinib and HMPL-013, while removing previous location terms and references to related topics like lung cancer.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.